Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

BACKGROUND: The increased resistance of the human malaria parasite Plasmodium falciparum to currently employed drugs creates an urgent call for novel anti-malarial drugs. Particularly, efforts should be devoted to developing fast-acting anti-malarial compounds in case clinical resistance increases t...

Descripción completa

Detalles Bibliográficos
Autores principales: Duffey, Maëlle, Sanchez, Cecilia P., Lanzer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861637/
https://www.ncbi.nlm.nih.gov/pubmed/29558913
http://dx.doi.org/10.1186/s12936-018-2279-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861637/
https://www.ncbi.nlm.nih.gov/pubmed/29558913
http://dx.doi.org/10.1186/s12936-018-2279-4

Ejemplares similares